Junko Okabe‐Kado

Induction of erythroid differentiation of K562 human leukemic cells by herbimycin A, an inhibitor of tyrosine kinase activity.

Y Honma, Junko Okabe‐Kado, Motoo Hozumi et al. · PubMed · 1989 · 117 citations

Hematological Malignancy, Signal Transduction, Tyrosine Protein Kinase +14

Identity of a differentiation inhibiting factor for mouse myeloid leukemia cells with NM23/nucleoside diphosphate kinase

Junko Okabe‐Kado, Takashi Kasukabe, Yoshio Honma et al. · Biochemical and Biophysical Research Communications · 1992 · 110 citations

Hematological Malignancy, Chromatin, Nm23/nucleoside Diphosphate Kinase +10

Combined treatment with cotylenin A and phenethyl isothiocyanate induces strong antitumor activity mainly through the induction of ferroptotic cell death in human pancreatic cancer cells

Takashi Kasukabe, Yoshio Honma, Junko Okabe‐Kado et al. · Oncology Reports · 2016 · 90 citations · Full text

Serum nm23-H1 protein as a prognostic factor in aggressive non-Hodgkin lymphoma

Nozomi Niitsu, Junko Okabe‐Kado, Masataka Okamoto et al. · Blood · 2001 · 74 citations

Expression of Ah receptor (TCDD receptor) during human monocytic differentiation

Shin-ichi Hayashio, Junko Okabe‐Kado, Yoshio Honma et al. · Carcinogenesis · 1995 · 72 citations